Past accomplishments of our group

Past accomplishments of our group

  • Set up prime-boost genetic vaccine Platform
  • Tumor stroma antigen identified and validated
  • Development of high efficacious monoclonal antibodies
  • More than 50 papers published in the field
  • IP protection for antigens, more immunogenic fusions and vectors
  • Candidate vaccines advanced to phase1 trials
  • Successful collaborations with Biotech Companies
  • Network with several clinical groups in Italy and outside

 

 

Takis Leadership

Follow Us on Linkedin

Takis is a biotech dedicated to cancer research. Our primary objective is the development of innovative therapies based on the principle that our immune system can be “instructed” to recognize the tumor and reject it as a foreign entity.
Visit our page
  • Terms of use
  • Privacy
  • Ethical code
  • This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Webmail